BRPI0815946A2 - método para tratar a isquemia em um individuo que precise, método para tratar uma condição médica que exija a regeneração e/ou o reparo do tecido conjutivo em um indivíduo que precise, uso de células aderentes de um tecido e artigo de fabricação - Google Patents

método para tratar a isquemia em um individuo que precise, método para tratar uma condição médica que exija a regeneração e/ou o reparo do tecido conjutivo em um indivíduo que precise, uso de células aderentes de um tecido e artigo de fabricação

Info

Publication number: BRPI0815946A2
Authority: BR; Brazil
Prior art keywords: individual; need; treating; tissue; repair
Prior art date: 2007-09-19

Application number

BRPI0815946A

Other languages

English (en)

Inventor

Toren Amir

Meiron Moran

Drori-Carmi Nitrit

Ofir Rachel

Aberman Zami

Original Assignee

Pluristem Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-19

Filing date

2008-09-02

Publication date

2018-06-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40118825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0815946(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-09-02 Application filed by Pluristem Ltd filed Critical Pluristem Ltd

2018-06-26 Publication of BRPI0815946A2 publication Critical patent/BRPI0815946A2/pt

2020-12-01 Publication of BRPI0815946B1 publication Critical patent/BRPI0815946B1/pt

2021-05-25 Publication of BRPI0815946B8 publication Critical patent/BRPI0815946B8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Developmental Biology & Embryology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Epidemiology (AREA)
Virology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Pregnancy & Childbirth (AREA)
Hematology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Transplantation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Materials For Medical Uses (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0815946A 2007-09-19 2008-09-02 artigo de fabricação BRPI0815946B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US96018407P	2007-09-19	2007-09-19
US60/960,184		2007-09-19
PCT/IL2008/001185 WO2009037690A1 (en)	2007-09-19	2008-09-02	Adherent cells from adipose or placenta tissues and use thereof in therapy

Publications (3)

Publication Number	Publication Date
BRPI0815946A2 true BRPI0815946A2 (pt)	2018-06-26
BRPI0815946B1 BRPI0815946B1 (pt)	2020-12-01
BRPI0815946B8 BRPI0815946B8 (pt)	2021-05-25

Family

ID=40118825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0815946A BRPI0815946B8 (pt)	2007-09-19	2008-09-02	artigo de fabricação

Country Status (18)

Country	Link
US (4)	US8529888B2 (pt)
EP (3)	EP3103463B1 (pt)
JP (5)	JP2010539228A (pt)
KR (4)	KR20100075924A (pt)
CN (2)	CN107028981B (pt)
AU (1)	AU2008300185B2 (pt)
BR (1)	BRPI0815946B8 (pt)
CA (1)	CA2699664C (pt)
ES (1)	ES2392729T5 (pt)
HR (1)	HRP20120887T4 (pt)
IL (4)	IL204566A (pt)
MX (1)	MX2010003019A (pt)
PL (1)	PL2200622T5 (pt)
PT (1)	PT2200622E (pt)
RU (2)	RU2709780C2 (pt)
SI (1)	SI2200622T2 (pt)
WO (1)	WO2009037690A1 (pt)
ZA (1)	ZA201001929B (pt)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060045872A1 (en)	2004-08-25	2006-03-02	Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco	Use of adipose tissue-derived stromal stem cells in treating fistula
EP3184631B1 (en)	2005-09-23	2020-08-12	TiGenix, S.A.U.	Cell populations having immunoregulatory activity, method for isolation and uses
EP1933852B1 (en)	2005-09-27	2018-12-19	TissueTech, Inc.	Amniotic membrane preparations and purified compositions and methods of use
WO2011132087A1 (en)	2010-04-23	2011-10-27	Pluristem Ltd.	Adherent stromal cells derived from plancentas of multiple donors and uses thereof
EP2183693B2 (en)	2007-07-23	2018-11-14	The Chinese University of Hong Kong	Diagnosing fetal chromosomal aneuploidy using genomic sequencing
US12180549B2 (en)	2007-07-23	2024-12-31	The Chinese University Of Hong Kong	Diagnosing fetal chromosomal aneuploidy using genomic sequencing
CN107028981B (zh)	2007-09-19	2021-04-20	普拉里斯坦有限公司	来自脂肪或胎盘组织的粘附细胞及其在治疗中的用途
KR101644659B1 (ko) *	2007-09-26	2016-08-01	안트로제네시스 코포레이션	인간 태반 관류액으로부터의 혈관형성 세포
CA2725637A1 (en) *	2008-05-27	2009-12-03	Pluristem Ltd.	Methods of treating inflammatory colon diseases
EP3539380A3 (en)	2008-08-20	2019-12-18	Celularity, Inc.	Improved cell composition and methods of making the same
SG190659A1 (en) *	2008-09-02	2013-06-28	Pluristem Ltd	Adherent cells from placenta tissue and use thereof in therapy
WO2010059828A1 (en)	2008-11-19	2010-05-27	Anthrogenesis Corporation	Amnion derived adherent cells
EP2507362A2 (en)	2009-11-30	2012-10-10	Pluristem Ltd.	Adherent cells from placenta and use of same in disease treatment
TW202011974A (zh) *	2010-04-07	2020-04-01	美商安瑟吉納西斯公司	利用胎盤幹細胞之血管新生
AU2013203479B2 (en) *	2010-04-07	2016-05-19	Celularity Inc.	Angiogenesis using placental stem cells
US9757419B2 (en)	2010-05-27	2017-09-12	Pluristem Ltd.	Skeletal muscle regeneration using mesenchymal system cells
EP2625264B1 (en)	2010-10-08	2022-12-07	Terumo BCT, Inc.	Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
AR093183A1 (es)	2010-12-31	2015-05-27	Anthrogenesis Corp	Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
EP2689008B1 (en) *	2011-03-22	2017-09-27	Pluristem Ltd.	Methods for treating radiation or chemical injury
MX349171B (es) *	2011-04-15	2017-07-17	Pluristem Ltd	Metodos y sistemas para cosechar celulas.
WO2012149486A1 (en)	2011-04-28	2012-11-01	Tissuetech, Inc.	Methods of modulating bone remodeling
AU2012262273B2 (en)	2011-06-01	2017-09-14	Celularity Inc.	Treatment of pain using placental stem cells
EP2718416B1 (en)	2011-06-06	2019-11-13	Regenesys bvba	Expansion of stem cells in hollow fiber bioreactors
MX2014000567A (es) *	2011-07-15	2014-05-01	Anthrogenesis Corp	Tratamiento de lesion por radiacion utilizando celulas adherentes derivadas del amnios.
WO2013070734A1 (en)	2011-11-07	2013-05-16	Chaudhry Hina W	Methods of cardiac repair
US9892230B2 (en)	2012-03-08	2018-02-13	The Chinese University Of Hong Kong	Size-based analysis of fetal or tumor DNA fraction in plasma
US9950014B2 (en)	2012-09-04	2018-04-24	Pluristem Ltd.	Methods for prevention and treatment of preeclampsia
RS53886B1 (sr)	2012-09-06	2015-08-31	Pluristem Ltd.	Uređaji i postupci za kultivaciju ćelija
JP6545102B2 (ja)	2013-01-18	2019-07-17	ミメディクスグループインコーポレイテッド	心病態を治療する方法
RU2019100033A (ru) *	2013-02-12	2019-02-12	Репликэл Лайф Сайенсиз Инк.	Композиции и способы для лечения и восстановления сухожилий
US10351910B2 (en)	2013-02-20	2019-07-16	Pluristem Ltd	Gene and protein expression properties of adherent stromal cells cultured in 3D
WO2014141111A1 (en)	2013-03-14	2014-09-18	Pluristem Ltd.	Methods for prevention and treatment of graft-versus-host disease
KR20160006694A (ko) *	2013-04-05	2016-01-19	클라우디아 질버버그	매트릭스 메탈로프로테나아제 및 그의 용도
WO2015004609A2 (en)	2013-07-09	2015-01-15	Pluristem Ltd.	Adherent cells from placenta and use thereof in treatment of injured tendons
EP3068866B1 (en)	2013-11-16	2018-04-25	Terumo BCT, Inc.	Expanding cells in a bioreactor
WO2015109329A1 (en)	2014-01-17	2015-07-23	Mimedx Group, Inc.	Method for inducing angiogenesis
EP3114206B1 (en)	2014-03-04	2020-07-29	Pluristem Ltd.	Systems and methods for growing and harvesting cells
CN106232800B (zh)	2014-03-25	2020-07-03	泰尔茂比司特公司	介质的被动替代
EP3198006B1 (en)	2014-09-26	2021-03-24	Terumo BCT, Inc.	Scheduled feed
KR101808762B1 (ko) *	2014-10-29	2017-12-14	차의과학대학교 산학협력단	C3 또는 C1r 보체를 분비하는 태반 유래 세포 및 이를 포함하는 조성물
US10364467B2 (en)	2015-01-13	2019-07-30	The Chinese University Of Hong Kong	Using size and number aberrations in plasma DNA for detecting cancer
WO2016151476A1 (en)	2015-03-23	2016-09-29	Pluristem Ltd.	Use of adherent stromal cells for enhancing hematopoiesis in a subject in need thereof
WO2017004592A1 (en)	2015-07-02	2017-01-05	Terumo Bct, Inc.	Cell growth with mechanical stimuli
WO2017039251A1 (ko) *	2015-08-28	2017-03-09	주식회사 차바이오텍	향상된 산후 부착형 세포 및 그의 용도
CA3012741A1 (en) *	2016-02-18	2017-08-24	Pluristem Ltd.	Methods and compositions for treating cancer and neoplasms
GB201604304D0 (en)	2016-03-14	2016-04-27	Tigenix S A U	Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
EP3464565A4 (en)	2016-05-25	2020-01-01	Terumo BCT, Inc.	CELL EXPANSION
CN109496236A (zh) *	2016-06-06	2019-03-19	普拉里斯坦有限公司	改变的粘附基质细胞及其产生和使用方法
US11685883B2 (en)	2016-06-07	2023-06-27	Terumo Bct, Inc.	Methods and systems for coating a cell growth surface
US11104874B2 (en)	2016-06-07	2021-08-31	Terumo Bct, Inc.	Coating a bioreactor
WO2018039294A1 (en)	2016-08-24	2018-03-01	Arthrex, Inc.	Tissue use for repair of injury
US12234441B2 (en)	2017-03-31	2025-02-25	Terumo Bct, Inc.	Cell expansion
US11624046B2 (en)	2017-03-31	2023-04-11	Terumo Bct, Inc.	Cell expansion
WO2018184028A2 (en)	2017-03-31	2018-10-04	Terumo Bct, Inc.	Cell expansion
CN106932571A (zh) *	2017-04-12	2017-07-07	广东国盛医学科技有限公司	基于rcn2标志物检测的心血管病检测方法及试剂盒
IL270114B2 (en)	2017-04-24	2024-01-01	Pluri Biotech Ltd	Methods and compounds for the treatment of neurological diseases
WO2018200606A1 (en) *	2017-04-25	2018-11-01	Abraham J And Phyllis Katz Cord Blood Foundation	Enriched cellular compositions and therapeutic use
WO2019132025A1 (ja) *	2017-12-28	2019-07-04	株式会社カネカ	接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
CN109810992A (zh) *	2019-02-01	2019-05-28	天津师范大学	一种编码牙鲆胞外ATP水解酶CD39的cDNA全长序列及其应用
KR102143840B1 (ko) *	2019-02-22	2020-08-12	송미연	손상된 성상교세포 치료방법
US11511017B2 (en)	2019-03-12	2022-11-29	Arthrex, Inc.	Ligament reconstruction
WO2020190885A1 (en) *	2019-03-15	2020-09-24	Celularity Inc.	Placenta derived adherent cells for improved xenoplantation
CN113365644A (zh) *	2019-03-27	2021-09-07	普拉里斯坦有限公司	用于美容和整容治疗以及刺激毛发生长的方法和组合物
US20200392448A1 (en) *	2019-06-14	2020-12-17	Ge Healthcare Uk Limited	Monitoring of Cell Expansion
KR20200000415A (ko) *	2019-12-24	2020-01-02	(주)안트로젠	면역 질환 또는 염증성 질환의 예방 또는 치료용 중간엽줄기세포 배양액 및 이의 제조방법
WO2022204315A1 (en)	2021-03-23	2022-09-29	Terumo Bct, Inc.	Cell capture and expansion
US20240293471A1 (en) *	2021-09-09	2024-09-05	Pluri Biotech Ltd.	Placental cell treatment for critical limb ischemia patient subpopulations
US12152699B2 (en)	2022-02-28	2024-11-26	Terumo Bct, Inc.	Multiple-tube pinch valve assembly
USD1099116S1 (en)	2022-09-01	2025-10-21	Terumo Bct, Inc.	Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (112)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL154600B (nl)	1971-02-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl)	1970-11-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl)	1970-12-28	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en)	1971-06-21	1975-08-26	Biological Developments	Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en)	1971-09-01	1974-12-10	W Dreyer	Immunological reagent and radioimmuno assay
US3867517A (en)	1971-12-21	1975-02-18	Abbott Lab	Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl)	1972-05-11	1983-06-01	Akzo Nv	Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en)	1973-03-12	1974-11-26	H Mcconnell	Process for assaying for biologically active molecules
US3935074A (en)	1973-12-17	1976-01-27	Syva Company	Antibody steric hindrance immunoassay with two antibodies
US3996345A (en)	1974-08-12	1976-12-07	Syva Company	Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en)	1974-09-19	1977-07-05	The Board Of Trustees Of Leland Stanford Junior University	Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en)	1975-11-13	1976-10-05	General Electric Company	Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en)	1976-10-26	1978-07-04	Corning Glass Works	Reverse sandwich immunoassay
US4879219A (en)	1980-09-19	1989-11-07	General Hospital Corporation	Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en)	1984-04-12	1991-04-30	The General Hospital Corporation	Multiepitopic immunometric assay
US4666828A (en)	1984-08-15	1987-05-19	The General Hospital Corporation	Test for Huntington's disease
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US4801531A (en)	1985-04-17	1989-01-31	Biotechnology Research Partners, Ltd.	Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5902741A (en)	1986-04-18	1999-05-11	Advanced Tissue Sciences, Inc.	Three-dimensional cartilage cultures
US4846835A (en) *	1987-06-15	1989-07-11	Grande Daniel A	Technique for healing lesions in cartilage
US5272057A (en)	1988-10-14	1993-12-21	Georgetown University	Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en)	1989-08-25	1993-03-09	Genetype Ag	Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5108989A (en) *	1990-04-04	1992-04-28	Genentech, Inc.	Method of predisposing mammals to accelerated tissue repair
US5486359A (en)	1990-11-16	1996-01-23	Osiris Therapeutics, Inc.	Human mesenchymal stem cells
US5281521A (en)	1992-07-20	1994-01-25	The Trustees Of The University Of Pennsylvania	Modified avidin-biotin technique
US5877295A (en) *	1992-09-30	1999-03-02	The Center For Blood Research	Antibodies which bind a subpopulation of Mac-1 (CD11b/CD18) molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogen
US5629186A (en)	1994-04-28	1997-05-13	Lockheed Martin Corporation	Porous matrix and method of its production
US5474687A (en) *	1994-08-31	1995-12-12	Activated Cell Therapy, Inc.	Methods for enriching CD34+ human hematopoietic progenitor cells
US5736396A (en)	1995-01-24	1998-04-07	Case Western Reserve University	Lineage-directed induction of human mesenchymal stem cell differentiation
US6132463A (en)	1995-05-19	2000-10-17	Etex Corporation	Cell seeding of ceramic compositions
JP3781433B2 (ja)	1995-11-16	2006-05-31	ケースウエスターンリザーブユニバーシティ	ヒト間葉幹細胞の試験管内軟骨形成誘導
US6197575B1 (en)	1998-03-18	2001-03-06	Massachusetts Institute Of Technology	Vascularized perfused microtissue/micro-organ arrays
FR2784284B1 (fr) *	1998-10-13	2000-12-15	Natural Implant Sa	Procede de preparation d'un implant dentaire par immersion dans une culture de cellules mesenchymateuses, dispositif de culture de cellules pour la preparation dudit implant et implant obtenu
US6153432A (en)	1999-01-29	2000-11-28	Zen-Bio, Inc	Methods for the differentiation of human preadipocytes into adipocytes
EP2208782B1 (en)	1999-02-04	2017-05-31	Pluristem Ltd.	Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
WO2000053795A1 (en)	1999-03-10	2000-09-14	University Of Pittsburgh Of The Commonwealth System Of Higher Education	Adipose-derived stem cells and lattices
US7582292B2 (en)	2000-02-26	2009-09-01	Artecel, Inc.	Adipose tissue derived stromal cells for the treatment of neurological disorders
AU3869501A (en)	2000-02-26	2001-09-03	Artecel Sciences Inc	Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
AU2001273992B2 (en)	2000-05-03	2005-08-04	Fidia Advanced Biopolymers S.R.L.	Biomaterials comprised of preadipocyte cells for soft tissue repair
EP2206772A3 (en)	2000-12-06	2010-08-04	Robert J. Hariri	Method of collecting placental stem cells
US20030032179A1 (en)	2000-12-06	2003-02-13	Hariri Robert J.	Post-partum mammalian placenta, its use and placental stem cells therefrom
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
WO2002063962A1 (en)	2001-02-14	2002-08-22	Hariri Robert J	Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
US20030180947A1 (en) *	2001-09-21	2003-09-25	J.H. David Wu	Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
US9597395B2 (en) *	2001-12-07	2017-03-21	Cytori Therapeutics, Inc.	Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US7504099B2 (en)	2001-12-27	2009-03-17	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Methods of inducing or enhancing connective tissue repair
NZ534643A (en)	2002-02-13	2010-06-25	Anthrogenesis Corp	Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
US20050118714A1 (en) *	2002-02-19	2005-06-02	Chul-Won Ha	Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood and differentation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
CA2479309A1 (en) *	2002-03-15	2003-12-24	Catherine A. Phillips	Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
WO2003082305A1 (en) *	2002-04-03	2003-10-09	Naohide Yamashita	Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells
US7498171B2 (en)	2002-04-12	2009-03-03	Anthrogenesis Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
EP1497435A4 (en)	2002-04-19	2005-07-27	Univ Pittsburgh	STEM CELLS DERIVED FROM PLAZENTA AND THEIR USES
US20040161419A1 (en)	2002-04-19	2004-08-19	Strom Stephen C.	Placental stem cells and uses thereof
CN1234429C (zh) *	2002-05-09	2006-01-04	中国人民解放军军事医学科学院野战输血研究所	一种人工皮肤及其制备方法与应用
CA2488013A1 (en) *	2002-05-30	2003-12-11	Celgene Corporation	Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
DK1512014T3 (da) *	2002-06-13	2009-10-05	Merck Patent Gmbh	Fremgangsmåder til identifikation af alloantigener samt anvendelse deraf til cancerbehandling og transplantation
US8455458B2 (en) *	2002-10-16	2013-06-04	Arthrodynamic Technologies, Animal Health Division, Inc.	Composition and method for treating connective tissue damage
CN1826137A (zh) *	2002-11-01	2006-08-30	博伊斯镇国家研究医院	α1β1整联蛋白的可诱导的配体和用途
CN1901802B (zh)	2003-02-20	2010-12-29	马克罗珀尔生物外科公司	用脂肪组织来源的细胞治疗心血管疾病的方法
BRPI0407694A (pt) *	2003-02-20	2006-03-01	Macropore Biosurgery Inc	métodos de usar células derivadas do tecido adiposo no tratamento de condições cardiovasculares
JP2004254674A (ja) *	2003-02-25	2004-09-16	Mutsumi Takagi	動物細胞の分化誘導培養方法
US20060172304A1 (en)	2003-02-27	2006-08-03	Elaine Fuchs	Method for modulating epithelial stem cell lineage
CN1548529A (zh) *	2003-05-09	2004-11-24	中国人民解放军军事医学科学院基础医	一种人胎盘间充质干细胞的分离方法
ES2568463T3 (es)	2003-06-27	2016-04-29	DePuy Synthes Products, Inc.	Regeneración y reparación de tejido neural usando células del postparto derivadas del cordon umbilical
EP1649007A4 (en) *	2003-07-17	2008-05-14	Gamida Cell Ltd	PROCESS FOR THE EX-VIVO EXPANSION OF STEM / PROVIDER CELLS
DE602004030254D1 (de)	2003-08-01	2011-01-05	Two Cells Co Ltd	Scaffoldfreies, selbstorganisiertes, 3 dimensionales, synthetisches gewebe
FR2859381B1 (fr)	2003-09-05	2008-07-25	Centre Nat Rech Scient	Utilisaton de cellules issues du tissu adipeux pour induire la formation d'un reseau vasculaire fonctionnel
CN1878470A (zh)	2003-09-17	2006-12-13	马克罗珀尔生物外科公司	在周围血管疾病和相关病症的治疗中使用再生细胞的方法
TWI338714B (en)	2003-12-02	2011-03-11	Cathay General Hospital	Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid
US7534606B2 (en)	2004-01-12	2009-05-19	National Health Research Institutes	Placental stem cell and methods thereof
WO2005068437A1 (en) *	2004-01-16	2005-07-28	Novartis Ag	2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis
JP4445765B2 (ja) *	2004-02-05	2010-04-07	グンゼ株式会社	細胞培養装置
WO2005093044A1 (en)	2004-03-22	2005-10-06	Osiris Therapeutics, Inc.	Mesenchymal stem cells and uses therefor
JP2007536936A (ja) *	2004-05-14	2007-12-20	ベクトン・ディキンソン・アンド・カンパニー	幹細胞集団および使用方法
CN1746296A (zh) *	2004-09-09	2006-03-15	中国人民解放军军事医学科学院基础医学研究所	一种基于胎盘来源间充质干细胞的组织工程化骨及其制造方法
CN1746295A (zh) *	2004-09-09	2006-03-15	中国人民解放军军事医学科学院基础医学研究所	一种基于胎盘来源间充质干细胞的组织工程化软骨及其制造方法
CN100336567C (zh) *	2004-10-19	2007-09-12	北京科宇联合干细胞生物技术有限公司	医用角膜贴片
EP1833496B1 (en)	2004-12-23	2013-07-31	Ethicon, Incorporated	Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
WO2006074075A2 (en)	2004-12-30	2006-07-13	Primegen Biotech, Llc	Adipose-derived stem cells for tissue regeneration and wound healing
US20070059288A1 (en) *	2005-03-31	2007-03-15	Dinsmore Jonathan H	Treatment for heart disease
WO2006105152A2 (en)	2005-03-31	2006-10-05	Stemnion, Inc.	Amnion-derived cell compositions, methods of making and uses thereof
US20080317720A1 (en)	2005-04-14	2008-12-25	Noritoshi Nagaya	Fat-Derived Progenitor Cell and Use Thereof
US8202551B2 (en) *	2005-06-15	2012-06-19	The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same
AU2006304277B2 (en) *	2005-10-13	2012-07-05	Celularity Inc.	Immunomodulation using placental stem cells
CA2624916A1 (en)	2005-10-13	2007-04-26	Anthrogenesis Corporation	Production of oligodendrocytes from placenta-derived stem cells
EP1937326B1 (en)	2005-10-21	2018-09-12	CellResearch Corporation Pte Ltd	Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom
JP5599568B2 (ja) *	2005-12-28	2014-10-01	エシコン・インコーポレイテッド	分娩後由来細胞を用いた末梢血管疾患の治療
KR101900809B1 (ko)	2005-12-29	2018-09-20	안트로제네시스 코포레이션	태반 줄기 세포 집단
GB0600972D0 (en) *	2006-01-18	2006-03-01	Univ Leeds	Enrichment of cells
WO2007091255A2 (en) *	2006-02-06	2007-08-16	Pluristem Ltd.	Method and apparatus for maintenance and expansion of hematopoietic stem cells from mononuclear cells
US20110293583A1 (en)	2006-03-23	2011-12-01	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
US20110171182A1 (en)	2006-03-23	2011-07-14	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
BRPI0709349A2 (pt) *	2006-03-23	2011-07-12	Pluristem Ltd	métodos para expansão celular e usos de células e de meios condicionados produzidos através deles para terapia
WO2011132087A1 (en)	2010-04-23	2011-10-27	Pluristem Ltd.	Adherent stromal cells derived from plancentas of multiple donors and uses thereof
EP1845154A1 (en)	2006-04-12	2007-10-17	RNL Bio Co., Ltd.	Multipotent stem cells derived from placenta tissue and cellular therapeutic agents comprising the same
DE102006043625B4 (de) *	2006-09-12	2012-02-23	Eberhard-Karls-Universität Tübingen Universitätsklinikum	Verfahren zur Isolierung und/oder Identifizierung von mesenchymalen Stammzellen (MSC)
US20080138415A1 (en) *	2006-09-26	2008-06-12	Mehboob Hussain	Composition and method for producing composition for constructing tissue, and tissue construct
EP3483263A1 (en) *	2006-10-23	2019-05-15	Celularity, Inc.	Methods and compositions for treatment of bone defects with placental cell populations
EP2687220A3 (en)	2007-02-12	2014-05-14	Anthrogenesis Corporation	Treatment of inflammatory diseases using placental stem cells
EP2578677A1 (en) *	2007-08-09	2013-04-10	Genzyme Corporation	Method of treating autoimmune disease with mesenchymal stem cells
CN107028981B (zh)	2007-09-19	2021-04-20	普拉里斯坦有限公司	来自脂肪或胎盘组织的粘附细胞及其在治疗中的用途
CA2725637A1 (en)	2008-05-27	2009-12-03	Pluristem Ltd.	Methods of treating inflammatory colon diseases
WO2010026573A1 (en)	2008-09-02	2010-03-11	Pluristem Ltd.	Methods of selection of cells for transplantation
SG190659A1 (en)	2008-09-02	2013-06-28	Pluristem Ltd	Adherent cells from placenta tissue and use thereof in therapy
US9096827B2 (en)	2008-09-02	2015-08-04	Pluristem Ltd.	Adherent cells from placenta tissue and use thereof in therapy
EP2507362A2 (en)	2009-11-30	2012-10-10	Pluristem Ltd.	Adherent cells from placenta and use of same in disease treatment
US9757419B2 (en)	2010-05-27	2017-09-12	Pluristem Ltd.	Skeletal muscle regeneration using mesenchymal system cells
US20140017209A1 (en)	2011-03-22	2014-01-16	Pluristem Ltd.	Methods for treating radiation or chemical injury
MX349171B (es)	2011-04-15	2017-07-17	Pluristem Ltd	Metodos y sistemas para cosechar celulas.
US9950014B2 (en)	2012-09-04	2018-04-24	Pluristem Ltd.	Methods for prevention and treatment of preeclampsia
RS53886B1 (sr)	2012-09-06	2015-08-31	Pluristem Ltd.	Uređaji i postupci za kultivaciju ćelija
CN108212246B (zh)	2012-10-31	2021-07-06	普拉里斯坦有限公司	用于解冻生物材料的方法和装置

2008
- 2008-09-02 CN CN201611144948.XA patent/CN107028981B/zh active Active
- 2008-09-02 HR HRP20120887TT patent/HRP20120887T4/hr unknown
- 2008-09-02 KR KR1020107008253A patent/KR20100075924A/ko not_active Ceased
- 2008-09-02 WO PCT/IL2008/001185 patent/WO2009037690A1/en not_active Ceased
- 2008-09-02 US US12/678,756 patent/US8529888B2/en active Active
- 2008-09-02 PT PT08789856T patent/PT2200622E/pt unknown
- 2008-09-02 RU RU2015141314A patent/RU2709780C2/ru active
- 2008-09-02 AU AU2008300185A patent/AU2008300185B2/en not_active Ceased
- 2008-09-02 PL PL08789856T patent/PL2200622T5/pl unknown
- 2008-09-02 RU RU2010109698/15A patent/RU2010109698A/ru unknown
- 2008-09-02 SI SI200830808T patent/SI2200622T2/sl unknown
- 2008-09-02 CN CN201611144950.7A patent/CN107050057B/zh active Active
- 2008-09-02 BR BRPI0815946A patent/BRPI0815946B8/pt active IP Right Grant
- 2008-09-02 ES ES08789856.5T patent/ES2392729T5/es active Active
- 2008-09-02 EP EP16166860.3A patent/EP3103463B1/en active Active
- 2008-09-02 KR KR1020167017340A patent/KR101738323B1/ko active Active
- 2008-09-02 CA CA2699664A patent/CA2699664C/en active Active
- 2008-09-02 KR KR1020157022477A patent/KR101738285B1/ko active Active
- 2008-09-02 EP EP08789856.5A patent/EP2200622B2/en active Active
- 2008-09-02 EP EP12177032.5A patent/EP2591789B2/en active Active
- 2008-09-02 MX MX2010003019A patent/MX2010003019A/es active IP Right Grant
- 2008-09-02 KR KR1020147022194A patent/KR20140107677A/ko not_active Ceased
- 2008-09-02 JP JP2010525491A patent/JP2010539228A/ja active Pending
2010
- 2010-03-17 IL IL204566A patent/IL204566A/en active IP Right Grant
- 2010-03-18 ZA ZA2010/01929A patent/ZA201001929B/en unknown
2013
- 2013-08-05 US US13/958,706 patent/US20180256648A9/en not_active Abandoned
2014
- 2014-02-13 US US14/180,039 patent/US9517248B2/en active Active
- 2014-06-27 JP JP2014132003A patent/JP5931132B2/ja active Active
2016
- 2016-01-26 JP JP2016012622A patent/JP2016094464A/ja active Pending
- 2016-11-14 IL IL248955A patent/IL248955B/en active IP Right Grant
- 2016-11-14 IL IL248956A patent/IL248956B/en active IP Right Grant
2017
- 2017-02-08 JP JP2017021090A patent/JP6294517B2/ja active Active
2018
- 2018-02-15 JP JP2018025190A patent/JP6560381B2/ja active Active
2020
- 2020-02-10 IL IL272587A patent/IL272587B2/en unknown
2022
- 2022-08-04 US US17/817,488 patent/US20220378847A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP2200622B1 (en)	2012-08-08
PT2200622E (pt)	2012-11-06
CN101861156A (zh)	2010-10-13
IL204566A0 (en)	2010-11-30
IL248955A0 (en)	2017-01-31
JP6560381B2 (ja)	2019-08-14
US8529888B2 (en)	2013-09-10
IL272587B2 (en)	2023-02-01
KR20140107677A (ko)	2014-09-04
EP3103463B1 (en)	2020-01-01
JP2010539228A (ja)	2010-12-16
US20140242039A1 (en)	2014-08-28
RU2010109698A (ru)	2011-09-27
KR101738323B1 (ko)	2017-05-19
HRP20120887T4 (hr)	2015-12-04
IL248955B (en)	2020-03-31
US20100209403A1 (en)	2010-08-19
CA2699664C (en)	2016-10-18
JP2014208682A (ja)	2014-11-06
JP2017095516A (ja)	2017-06-01
EP2200622A1 (en)	2010-06-30
RU2015141314A3 (pt)	2019-03-14
US20180256648A9 (en)	2018-09-13
IL204566A (en)	2016-11-30
EP2591789A3 (en)	2014-01-01
US9517248B2 (en)	2016-12-13
HK1145800A1 (en)	2011-05-06
ES2392729T3 (es)	2012-12-13
JP2016094464A (ja)	2016-05-26
ZA201001929B (en)	2011-02-23
JP5931132B2 (ja)	2016-06-08
AU2008300185B2 (en)	2013-09-05
EP2200622B2 (en)	2015-07-29
WO2009037690A1 (en)	2009-03-26
CN107028981B (zh)	2021-04-20
SI2200622T1 (sl)	2013-01-31
EP2591789B2 (en)	2022-07-20
BRPI0815946B8 (pt)	2021-05-25
CA2699664A1 (en)	2009-03-26
RU2015141314A (ru)	2018-12-26
IL272587B (en)	2022-10-01
SI2200622T2 (sl)	2015-09-30
PL2200622T3 (pl)	2013-01-31
ES2392729T5 (es)	2015-08-28
PL2200622T5 (pl)	2016-08-31
JP6294517B2 (ja)	2018-03-14
EP2591789A2 (en)	2013-05-15
HK1180241A1 (en)	2013-10-18
IL248956A0 (en)	2017-01-31
IL272587A (en)	2020-03-31
US20220378847A1 (en)	2022-12-01
AU2008300185A1 (en)	2009-03-26
BRPI0815946B1 (pt)	2020-12-01
KR20160081994A (ko)	2016-07-08
CN107050057A (zh)	2017-08-18
HRP20120887T1 (en)	2012-12-31
IL248956B (en)	2019-07-31
RU2709780C2 (ru)	2019-12-20
EP3103463A1 (en)	2016-12-14
JP2018109031A (ja)	2018-07-12
CN107028981A (zh)	2017-08-11
KR101738285B1 (ko)	2017-05-29
EP2591789B1 (en)	2016-06-22
KR20100075924A (ko)	2010-07-05
KR20150100959A (ko)	2015-09-02
US20130323213A1 (en)	2013-12-05
CN107050057B (zh)	2021-04-20
MX2010003019A (es)	2010-04-30

Publication	Publication Date	Title
BRPI0815946A2 (pt)	2018-06-26	método para tratar a isquemia em um individuo que precise, método para tratar uma condição médica que exija a regeneração e/ou o reparo do tecido conjutivo em um indivíduo que precise, uso de células aderentes de um tecido e artigo de fabricação
BRPI0809655A2 (pt)	2014-10-07	Método para tratar uma condição em um mamífero, composição farmacêutica, e, kit
BRPI0819075A2 (pt)	2014-10-07	Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico
BRPI0908503A2 (pt)	2015-09-29	partícula com um diâmetro menor que 2mm, e, composição para o tratamento de tecidos
BRPI0916820A2 (pt)	2015-11-03	processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição de superfície em um paciente, e, uso de microcápsulas
BRPI0816097A2 (pt)	2016-11-01	composição farmacêutica, método para tratar eritema em um paciente com rosácea, e, uso de uma composição.
EP2303183A4 (en)	2015-11-04	SURGICAL SUTURES INCORPORATED IN STEM CELLS OR OTHER BIOACTIVE MATERIALS
EP2092455A4 (en)	2012-09-05	EXPANDED STRUCTURES FOR REPAIR AND REGENERATION OF INTERVERTEBRAL DISCS AND ARTICULATION ELEMENTS
BRPI0920383A2 (pt)	2016-03-22	método para minimizar o diâmetro de uma solução de uréia, solução de uréia e uso de um tensoativo em solução de uréia
BRPI0814776A2 (pt)	2015-03-03	Método para manter consistência para tratamentos de distribuição de droga em aerossol, e, aparelho para distribuição de droga em aerossol
BRPI0810806A2 (pt)	2014-10-29	Método para tratar uma lesão cutânea em um indivíduo
BRPI0922786A2 (pt)	2019-09-24	sistemas de âncora-em-âncora para uso em fixação de osso
BRPI0908889A2 (pt)	2015-09-15	polipeptídeo omci ou polinucleotídeo que codifica o mesmo, método para tratar ou prevenir uma doença ou condição mediada por um leucotrieno ou hidroxieicosanóide em um paciente, e, composição
BRPI0915986A2 (pt)	2015-11-03	composição, métodos para tratar uma condição, para retardar o início de uma condição, para reduzir o risco em um indivíduo de adquirir uma condição e para alterar a expressão de um ou mais genes em um indivíduo
BRPI0912386A2 (pt)	2016-07-26	composto, e, métodos para melhorar memória em um indivíduo e para tratar condições relacionadas a uma quinase
BR112012000690A2 (pt)	2017-05-30	passador de sutura, conjunto de agulhas para uso em um passador de sutura, método para passar sutura através de tecido e método para tratamento de uma articulação do quadril
BR112012008854A2 (pt)	2015-09-22	combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, método para tratar câncer em um ser humano
BRPI0906244A2 (pt)	2015-06-30	Composto, composição farmacêutica, método para tratar um distúrbio cognitivo, psicótico, mediado por neurotransmissores ou um distúrbio neuronal em um indivíduo, uso de um composto e kit
BRPI0822802A2 (pt)	2015-09-01	Biomaterial na forma de hidrogel injetável, biomaterial derivado do cordão umbilical humano, processo para a obtenção do biomaterial, processo para a obtenção do biomaterial obtido e uso do biomaterial
BRPI0906245A2 (pt)	2015-06-30	Composto, método para tratar um distúrbio cognitivo, psicótico, mediado por neurotransmissor ou um distúrbio neuronal em indivíduo, uso de um composto, composição farmacêutica e kit
BRPI0815020A2 (pt)	2015-03-10	Composto, e, métodos de aliviar um efeito colateral de um opiato em um paciente que recebeu um opiato, e de melhorar função do intestino pós-operatório em um paciente que se submeteu a cirurgia.
BRPI0921317A2 (pt)	2017-06-06	composto, composição farmacêutica, e, método para tratar ou prevenir uma patologia relacionada com abeta em um mamífero
BRPI0811059A2 (pt)	2017-05-09	combinação, composição farmacêutica, método para tratar câncer em um animal de sangue quente, e, uso de uma combinação
BRPI0822095A2 (pt)	2014-10-07	Método para reduzir o sangramento e/ou hematoma em um paciente
BRPI0818869A2 (pt)	2015-05-05	Placa para fixação em uma parte alvo de osso a ser tratada, e, método.

Legal Events

Date	Code	Title	Description
2018-07-03	B15I	Others concerning applications: loss of priority
2018-07-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-07-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-09-18	B12F	Other appeals [chapter 12.6 patent gazette]
2019-12-03	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2019-12-24	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-04-14	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-08-04	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-11-17	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-12-01	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/12/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/09/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF